Ivarmacitinib ointment for the treatment of adults with mild-to-moderate atopic dermatitis: phase 3 part of a randomized, double-blind, placebo-controlled, phase 2/3 clinical trial
1. 系统已在2025-12-26 11:17:02对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1093/bjd/ljaf482
文献链接: https://academic.oup.com/bjd/advance-article/doi/10.1093/bjd/ljaf482/8361728
其他信息:
出版社: Oxford University Press (OUP)
作者: Duoqin Wang; Jiyuan Wu; Qing Guo; Zhiming Li; Liming Wu; Yumei Li; Jingyi Li; Jinyan Wang; Xiaohua Tao; Jianyun Lu; Linfeng Li; Sujun Liu; Siping Zhang; Guohong Hu; Xunyi Dai; Fuqiu Li; Xiaoman Gao; Rong Xiao; Yangfeng Ding; Jiande Han; Chao Ji; Hao Cheng; Rupeng Wang; Zhiqiang Song; Qingchun Diao; Xiuping Han; Rixin Chen; Hui Wang; Pan Liu; Jinhua Xu
全文下载地址: https://academic.oup.com/bjd/advance-article-pdf/doi/10.1093/bjd/ljaf482/65660634/ljaf482.pdf
